Relationships Between Fasting Plasma Glucose Levels and Insulin Secretion During Intravenous Glucose Tolerance Tests

1976 ◽  
Vol 42 (2) ◽  
pp. 222-229 ◽  
Author(s):  
JOHN D. BRUNZELL ◽  
R. PAUL ROBERTSON ◽  
ROGER L. LERNER ◽  
WILLIAM R. HAZZARD ◽  
JOHN W. ENSINCK ◽  
...  
1999 ◽  
Vol 69 (1) ◽  
pp. 27-31 ◽  
Author(s):  
Sakamoto ◽  
Wakabayashi ◽  
Sakamoto

To investigate the effects of vitamin K (VK) on pancreatic function, intravenous glucose tolerance tests were performed in rats fed with and without low VK diet (inclucing less than 20% required vitamin K1). Plasma glucose and immuno-reactive insulin (IRI) were determined. It was found that at 0 min., plasma glucose and IRI levels in low VK group were slightly less than in the control (glucose, 204.5 ± 21.7 vs. 229 ± 19.6 mg/dl, IRI, 6.6 ± 1.3 vs. 9.3 ± 1.8 ng/ml mean ± SEM). At 3 min. after glucose administration, plasma glucose was higher (391.8 ± 25.6 vs. 371.8 ± 18.7 mg/dl) and IRI, lower (11.8 ± 2.1 vs. 18.2 ± 3.6 ng/ml) in the low VK group. The disappearance rate of plasma glucose in the low VK group at 5–10 min. was significantly less than in the control (6.7 ± 2.2 vs. 11.9 ± 1.8 mg/ dl/min.). Incremental IRI area at 0 to 5 min. in the low VK group is less than in the control (15.2 ± 4.4 vs. 25.0 ± 9.1 ng/ml/min.), but at 5–60 min. and 0–60 min., it was found to be significantly higher compared to the control (210.3 ± 55.2 vs. 32.5 ± 47.1 ng/ml/min. at 5–60 min.). Dietary low VK intake would thus appear to induce a tendency of poor early insulin response, and late hyperinsulinemia to the glucose load in rats.


2004 ◽  
Vol 106 (6) ◽  
pp. 645-652 ◽  
Author(s):  
Leslie J. C. BLUCK ◽  
Allan T. CLAPPERTON ◽  
Cheryl V. KIDNEY ◽  
W. Andy COWARD

The quantity of deuterated glucose customarily given in labelled IVGTTs (intravenous glucose tolerance tests) changes the isotopic composition of the subject's body water enough to be detected by mass spectrometric techniques. Glucose undergoing direct glycogenesis does not contribute label to the body water pool, and isotope incorporated into it must have come from glucose that has either been oxidized or undergone indirect glycogenesis. By subtracting the amount of label found in body water from the total amount of glucose utilized, as calculated from the minimal model of glucose disappearance, it should be possible to study the partitioning of the dose given between direct glycogenesis in skeletal muscle and other metabolic pathways. To establish these principles, we used isotope ratio MS to determine body water composition in groups of healthy (n=7; mean weight, 76 kg; fasting plasma glucose and insulin, 5.1 mmol and 40 pmol respectively) and Type II diabetic (n=5; mean weight, 84 kg; fasting plasma glucose and insulin, 6.2 mmol and 75 pmol respectively) subjects undergoing IVGTTs. It was found that, for healthy subjects, 31% of the dose given was utilized in direct glycogenesis and this was decreased to 15% in diabetes. Defects in muscle glycogen synthesis in diabetes of the same order are well known from magnetic resonance studies. We conclude that measurement of label incorporation into body water is potentially useful for investigation of the metabolism of a glucose load in vivo during an IVGTT.


1970 ◽  
Vol 39 (2) ◽  
pp. 259-269 ◽  
Author(s):  
J. W. H. Doar ◽  
D. G. Cramp ◽  
D. S. J. Maw ◽  
M. Seed ◽  
V. Wynn

1. Blood pyruvate and lactate levels during oral and intravenous glucose tolerance tests are described in obese and non-obese non-diabetic, maturity-onset diabetic and insulin-requiring diabetic groups of women. 2. Mean fasting blood pyruvate levels were similar in non-diabetic, maturity-onset diabetic and insulin-requiring diabetic subjects of similar degree of obesity. Mean levels were higher in the obese groups of non-diabetic and maturity-onset diabetic subjects compared to those of non-obese subjects of similar degree of glucose tolerance. 3. After oral glucose administration similar mean increases of blood pyruvate levels above the fasting base-line were found in non-diabetic and maturity-onset diabetic subjects matched for degree of obesity. 4. Peak oral glucose tolerance test blood pyruvate levels were generally delayed in the maturity-onset diabetic subjects and mean blood pyruvate levels were elevated above those of the non-diabetic subjects during the later stages of the test. Qualitatively similar changes occurred during intravenous glucose tolerance tests. 5. Mean blood lactate/pyruvate ratios were similar in non-obese and obese non-diabetic and maturity-onset diabetic groups of subjects and changed little after oral glucose administration.


Sign in / Sign up

Export Citation Format

Share Document